With globalization, the pharmaceutical industry is expanding rapidly. Healthcare stakeholders require a clearer understanding of market dynamics and business opportunities. Competition is growing; analytics is changing the nature of how businesses and governments work.
E*HealthLine’s leading pharmaceutical intelligence capabilities, enables our global clientele to immediately adapt to new market trends policies and healthcare reforms. The company’s comprehensive network of domestic and international relationships, offer powerful resources to solutions designed to assist clientele in varied influences regarding drug treatment and dispensing behavior. This includes detailed and integrated views of provider, payer and patient dynamics.
The company provides a range of decision support tools and client services to analyze product performance and market trends, transforming information into actionable strategies.
E*HealthLine offers comprehensive and accurate reference data sets that links prescribers and their affiliations with group practices, hospitals, clinics and other healthcare organizations, serving as the foundation for pharmaceutical organizations to identify, quantify and customize operational commercial opportunities.
Organizations can seamlessly manage customer information from disparate sources to derive strategic insight that can improve decision-making and maximize business opportunities.
E*HealthLine’s leading edge position within the healthcare industry stems from monitoring highly relevant and consistent metrics in market change. The company continuously analyzes change in trends with an outreach and focus on global distribution channels and emerging markets.
Global and or multinational pharmaceutical leaders require powerful analytical and business intelligence tools to obtain vital information relating to ongoing opportunities in today’s complex and dynamic marketplace. Consistent and reliable views of the marketplace and competition enable performance tracking at the national, international, or regional level.
E*HealthLine’s advanced analytics and business intelligence ecosystem technology captures the most relevant information with a focus on:
E*HealthLine’s Pharmaceutical Analytic tracks pharmaceutical companies and provides a timely and cost-effective view of estimated product volumes, trends and market share.
E*HealthLine tracks information and data at every level, measuring the impact of key industry events to include product launches, sales and prescription patterns and line extensions benefit from monthly and quarterly, broad-view update.
E*HealthLine assist their clientele in making optimal selections through commercial evaluations and active sourcing strategies:
E*HealthLine’s data analytics are powered by a web-based tools that enables brand and competitive measurement and portfolio planning.
In today’s marketplace, there is an increasing focus on healthcare values, consisting of new decision makers, new decision criteria and new decision points. Integrated Delivery Networks (IDNs) are now regional power players and have emerged as powerful catalysts for change, while payers, government, group practice organizations and corporate parents are also playing a major role in treatment protocols and the delivery of healthcare. In this environment, it is critical for pharmaceutical companies to understand all the stakeholders and the forces that influence their behavior and decisions. Collecting and managing customer information, as well as bridging individual user groups within healthcare organizations, requires innovative tools and technology.
Learn more about Pharmaceutical Analytics - Download Brochure - Request a Demo